ZURICH, March 12, 2013 /PRNewswire/ --
Cytos Biotechnology Ltd (SIX:CYTN) today announced the appointment of Matthias Alder as Executive Vice President for Corporate Development and Legal Affairs and Cheryl Lassen as Vice President for Clinical Development. Philipp Mueller , Executive Vice President Clinical Development, will retire at the end of March 2013.
"We welcome Matthias Alder and Cheryl Lassen to our team. They bring significant additional experience and leadership to Cytos, which we believe will be critical to shape and execute our CYT003 program and corporate strategy," commented Christian Itin , PhD, CEO and Chairman of Cytos, and continued: "We thank Philipp Mueller for his many contributions and in particular for his work on the CYT003 program in allergic asthma and rhinitis, which forms the basis and focus of Cytos today. We are very grateful that Philipp will continue to work with Cytos as a consultant and wish him all the best for his future."
Matthias Alder joins Cytos as Executive Vice President Corporate Development and Legal Affairs. He has more than 19 years' of business, transactional and legal experience in the pharmaceutical and biotechnology industries. Most recently, he served as Senior Vice President Administration, General Counsel and Secretary of Micromet, Inc., a formerly Nasdaq-listed biopharmaceutical company located in Rockville, MD and Munich, Germany that was acquired by Amgen in 2012 for US$1.2 billion in cash. Prior to joining Micromet, he was a partner in the Life Sciences Transactions Practice at Cooley LLP, a renowned technology and life sciences-focused US law firm, where he speciali
|SOURCE Cytos Biotechnology Ltd|
Copyright©2012 PR Newswire.
All rights reserved